Pletal and Sepsis - a phase IV clinical study of FDA data

Summary:

Sepsis is reported as a side effect among people who take Pletal (cilostazol), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have High blood pressure.

The phase IV clinical study analyzes which people have Sepsis when taking Pletal. It is created by eHealthMe based on reports of 6,279 people who have side effects when taking Pletal from the FDA, and is updated regularly.

What is Pletal?

Pletal has active ingredients of cilostazol. It is often used in blockage of leg arteries. eHealthMe is studying from 6,341 Pletal users. Check the latest studies of Pletal.

What is Sepsis?

Sepsis (a severe blood infection that can lead to organ failure and death) is found to be associated with 2,523 drugs and 3,259 conditions by eHealthMe. Check the latest studies of Sepsis.

On Jul, 20, 2026

6,279 people reported to have side effects when taking Pletal.
Among them, 80 people (1.27%) have Sepsis.

Among these 80 people:

How long have people been on Pletal when they have Sepsis? *

What is the gender of people who have Sepsis when taking Pletal? *

female: 47.44 %
male: 52.56 %

What is the age of people who have Sepsis when taking Pletal? *

What are other drugs people take besides Pletal? *

What are other side effects people have besides Sepsis? *

Diarrhea: 15 people, 18.75%
Anaemia (lack of blood): 14 people, 17.50%
Pneumonia: 12 people, 15.00%
Nausea (feeling of having an urge to vomit): 11 people, 13.75%
Nausea And Vomiting: 11 people, 13.75%
Hypotension (abnormally low blood pressure): 11 people, 13.75%
Headache (pain in head): 9 people, 11.25%
Cellulitis (infection under the skin): 9 people, 11.25%
Fever: 9 people, 11.25%
Cardiac Failure Congestive: 9 people, 11.25%

What are the existing conditions these people have? *

High Blood Pressure: 11 people, 13.75%
Diabetes: 10 people, 12.50%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 6.25%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 4 people, 5.00%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 4 people, 5.00%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 4 people, 5.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 5.00%
Liver Disorder (liver diseases): 4 people, 5.00%
Oedema (fluid collection in tissue): 4 people, 5.00%
Chronic Renal Failure (kidney failure): 3 people, 3.75%

* Approximation only. Some reports may have incomplete information.

Do you take Pletal and have Sepsis?

- Check whether Sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pletal:

Pletal (6,341 reports)

Sepsis treatments and more:

Sepsis (140,102 reports)

Browse all side effects of Pletal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sepsis:

Sepsis (2,523 drugs)

Browse all the conditions that are associated with Sepsis:

Sepsis (3,259 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cilostazol (the active ingredients of Pletal) and Pletal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.